Surgical quality in trials of adjuvant cancer therapy

Journal of Surgical Oncology

Volumn 80, Issue 4, 2002, Pages 177-180

  Hundahl, Scott A ^a,b  

^a QUEEN S MEDICAL CENTER   (United States)

^b Queen's Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; GASTROINTESTINAL CARCINOMA; LYMPHADENECTOMY; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; SALVAGE THERAPY; STOMACH CANCER;

CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; MULTICENTER STUDIES; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; QUALITY OF HEALTH CARE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0036335104     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10123     Document Type: Editorial

References (29)

1. Influence of hospital-and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy
2. Surgeon-related factors and outcome in rectal cancer
3. Influence of surgery on metachronous distant metastases and survival in rectal cancer
4. Symptomatic recurrences of carcinoma of the rectum and sigmoid. The influence of radiotherapy on the quality of life
5. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision
6. Prognostic significance of radial margins of clearance in rectal cancer
7. Impact of surgical and pathologic variables in rectal cancer: A United States community and cooperative group report
8. Recurrence and survival after total mesorectal excision for rectal cancer
9. Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997
10. Total mesorectal excision in the operative treatment of carcinoma of the rectum
11. Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome
12. Local recurrence following total mesorectal excision for rectal cancer
13. Surgical treatment of adenocarcinoma of the rectum
14. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
15. Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
16. Surgical treatment variation in a prospective randomized trial of postoperative chemoradiotherapy for gastric cancer-the impact of under-treatment
17. Extended lymph-node dissection for gastric cancer
18. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial
19. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma
20. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer
21. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
22. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
23. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis
24. The implications of surgical quality assurance in cancer clinical trials
25. Improvement in survival after excision of primary tumor in stage III neuroblastoma
26. Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma
27. Quality assurance in surgical oncology (QASO) within the European Organization for Research and Treatment of Cancer (EORTC): Current status and future prospects
28. Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer
29. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial